AXA Framlington Biotech Fund R USD AccRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 9.01 | -7.04 | 17.52 | 31.57 | 2.03 | 3.59 | 0.96 | 6.95 |
+/- Category | -1.28 | 0.92 | -2.68 | 5.60 | 11.06 | 11.42 | 2.25 | 7.50 |
+/- Category Index | -6.18 | -5.19 | 0.81 | -1.37 | 1.73 | 1.12 | -6.37 | -10.92 |
% Rank in Category | 63 | 54 | 66 | 19 | 20 | 24 | 33 | 18 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.76 | -1.11 | 1.05 |
1 Week | 5.23 | -0.81 | 4.25 |
1 Month | 5.15 | 1.27 | 3.25 |
3 Months | 10.19 | 9.14 | -1.37 |
6 Months | 8.95 | 7.15 | -7.20 |
YTD | 10.55 | 8.44 | -7.37 |
1 Year | 20.39 | 9.87 | -15.97 |
3 Years Annualised | 6.12 | 10.15 | -2.41 |
5 Years Annualised | 9.67 | 2.34 | -3.21 |
10 Years Annualised* | 9.81 | -0.01 | -2.23 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.24 | 2.59 | - | - |
2023 | -4.18 | -1.84 | 1.08 | 6.20 |
2022 | -8.70 | -0.26 | 14.97 | -1.05 |
2021 | -6.53 | 8.44 | 4.34 | -3.53 |
2020 | 0.05 | 28.49 | -2.58 | 5.06 |
2019 | 16.22 | -1.09 | -9.15 | 12.54 |
|
Advertisement |